Donaldson
DCI NYSE Industrial Machinery & Supplies & Components Financials FY2017βFY2026
Donaldson's revenue rose 5.3% to $3.9 billion in fiscal 2026. Its operating margin was 15.4%, up from 13.4% a year earlier. Free cash flow was $426 million, up 25.4%. It paid out $252 million in dividends and buybacks, 59% of free cash flow. The diluted share count fell 2.1%.
What Donaldson does
No business description yet.
- Legal name
- Donaldson Company, Inc.
- Fiscal year ends
- July 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0000029644-26-000085
0000029644
Revenue and margins
Donaldson had $3.9B of revenue in fiscal 2026, up 5.3% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 9.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $426M in fiscal 2026, 11.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Donaldson returned $252M to shareholders in fiscal 2026, 59% of free cash flow. The diluted share count fell 2.1%.
Value Donaldson yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.1B and divides by 117.9M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 22.0x Β· peers 26.5x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Donaldson can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $193M | $187M | $233M | $180M | $250M |
| Debt incl. finance leases | $650M | $658M | $538M | $671M | $1.3B |
| Net debt / EBITDA | 0.9x | 0.8x | 0.5x | 0.8x | 1.5x |
| Debt / equity | 0.6x | 0.5x | 0.4x | 0.5x | 0.8x |
| Interest coverage | 29.8x | 25.0x | 25.4x | 20.5x | 16.7x |
| Current ratio | 2.2x | 1.7x | 1.8x | 1.9x | 2.1x |
| Quick ratio | 1.4x | 1.2x | 1.2x | 1.3x | 1.4x |
| Total assets | $2.6B | $2.8B | $2.9B | $3.0B | $4.0B |
| Total liabilities | $1.5B | $1.4B | $1.4B | $1.5B | $2.2B |
| Shareholders' equity | $1.1B | $1.3B | $1.5B | $1.5B | $1.8B |
| Net debt (β = net cash) | $457M | $470M | $306M | $491M | $1.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$8.6M
5 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Tod E. CarpenterChairman, President and CEO, Director | Sold | 31,968 | $91.10 | $2.9M | Form 4 |
| Aug 31, 2026 | Tod E. CarpenterChairman, President and CEO, Director | Sold | 3,032 | $91.00 | $0.3M | Form 4 |
| Apr 14, 2026 | James OwensDirector | Sold | 13,753 | $89.21 | $1.2M | Form 4 |
| Apr 13, 2026 | James OwensDirector | Sold | 5,921 | $89.02 | $0.5M | Form 4 |
| Apr 10, 2026 | James OwensDirector | Sold | 126 | $88.82 | $0.0M | Form 4 |
| Mar 26, 2026 | Guillermo BrisenoPresident | Sold | 20,600 | $84.97 | $1.8M | Form 4 |
| Dec 9, 2025 | Bradley J. PogalzChief Financial Officer | Sold | 566 | $91.57 | $0.1M | Form 4 |
| Dec 5, 2025 | Ajita G RajendraDirector | Sold | 19,800 | $92.04 | $1.8M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 5 / 9 | 7 / 9 |
| Accruals ratio | β2.8% | β1.8% | β1.2% |
| Altman Z'' | 6.49 | 6.53 | 5.66 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Donaldson DCI | $10.0B | 5.3% | 15.4% | 11.0% | 19.4% | 22.0x | 7 | |
| ITT ITT | $17.1B | 8.5% | 17.4% | 13.9% | 16.8% | 37.2x | 7 | Compare β |
| Valmont Industries VMI | $8.5B | 0.7% | 10.1% | 7.6% | 17.9% | 17.0x | 7 | Compare β |
| Fortive FTV | $18.8B | 1.9% | 17.3% | 23.5% | 5.7% | 36.1x | 5 | Compare β |
| Pentair PNR | $9.1B | 2.3% | 20.5% | 17.9% | 14.0% | 13.5x | 9 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.4B | $2.7B | $2.8B | $2.6B | $2.9B | $3.3B | $3.4B | $3.6B | $3.7B | $3.9B |
| Gross profit | $821M | $936M | $948M | $872M | $972M | $1.1B | $1.2B | $1.3B | $1.3B | $1.3B |
| Research and development | $54.7M | $59.9M | $62.3M | $61.2M | $67.8M | $69.1M | $78.1M | $93.6M | $87.8M | $76.1M |
| Operating income | $324M | $377M | $388M | $340M | $385M | $444M | $480M | $544M | $495M | $600M |
| Interest expense | $19.5M | $21.3M | $19.9M | $17.4M | $13.0M | $14.9M | $19.2M | $21.4M | $24.2M | $36.0M |
| Pretax income | $322M | $364M | $375M | $335M | $381M | $438M | $469M | $535M | $492M | $586M |
| Income tax | $89.2M | $183M | $108M | $78.2M | $94.1M | $106M | $110M | $121M | $125M | $132M |
| Net income | $233M | $180M | $267M | $257M | $287M | $333M | $359M | $414M | $367M | $454M |
| Diluted EPS | $1.74 | $1.36 | $2.05 | $2.00 | $2.24 | $2.66 | $2.90 | $3.38 | $3.05 | $3.85 |
| Diluted shares | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.12B | 0.12B | 0.12B | 0.12B |
| Cash flow | ||||||||||
| Cash from operations | $318M | $263M | $346M | $387M | $402M | $253M | $545M | $493M | $419M | $494M |
| Capital expenditure | $65.9M | $97.5M | $151M | $124M | $59.0M | $85.5M | $119M | $85.6M | $78.9M | $67.4M |
| Free cash flow | $252M | $165M | $195M | $263M | $343M | $167M | $426M | $407M | $340M | $426M |
| Depreciation and amortization | $75.2M | $76.7M | $81.1M | $87.6M | $95.3M | $93.8M | $92.3M | $98.4M | $99.5M | $106M |
| Stock-based compensation | $9.1M | $16.7M | $15.0M | $15.2M | $14.2M | $20.4M | $20.4M | $22.0M | $24.0M | $24.7M |
| Acquisitions | $32.2M | $0.5M | $96.0M | $6.5M | $0.0M | $68.9M | $209M | $2.0M | $2.4M | $823M |
| Share buybacks | $140M | $122M | $129M | $94.3M | $142M | $171M | $142M | $163M | $332M | $111M |
| Dividends paid | $92.4M | $94.7M | $99.7M | $106M | $107M | $110M | $114M | $123M | $132M | $141M |
| Dividends and buybacks | $233M | $217M | $229M | $201M | $249M | $281M | $256M | $286M | $463M | $252M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $308M | $205M | $178M | $237M | $223M | $193M | $187M | $233M | $180M | $250M |
| Total debt | $611M | $543M | $637M | $629M | $512M | $650M | $658M | $538M | $671M | $1.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $1.2B | $1.1B | $1.1B | $1.1B | $1.2B | $1.4B | $1.3B | $1.4B | $1.5B | $1.7B |
| Current liabilities | $484M | $469M | $483M | $407M | $607M | $630M | $756M | $783M | $757M | $804M |
| Inventory | $294M | $334M | $333M | $323M | $385M | $502M | $418M | $477M | $514M | $539M |
| Property and equipment, net | $485M | $509M | $589M | $632M | $618M | $594M | $653M | $646M | $645M | $633M |
| Total assets | $2.0B | $2.0B | $2.1B | $2.2B | $2.4B | $2.6B | $2.8B | $2.9B | $3.0B | $4.0B |
| Total liabilities | $1.1B | $1.1B | $1.2B | $1.2B | $1.3B | $1.5B | $1.4B | $1.4B | $1.5B | $2.2B |
| Shareholders' equity | $855M | $858M | $893M | $993M | $1.1B | $1.1B | $1.3B | $1.5B | $1.5B | $1.8B |
| Margins | ||||||||||
| Gross margin | 34.6% | 34.2% | 33.3% | 33.8% | 34.1% | 32.3% | 33.8% | 35.5% | 34.9% | 34.6% |
| Operating margin | 13.6% | 13.8% | 13.7% | 13.2% | 13.5% | 13.4% | 14.0% | 15.2% | 13.4% | 15.4% |
| EBITDA margin | 16.8% | 16.6% | 16.5% | 16.6% | 16.8% | 16.3% | 16.7% | 17.9% | 16.1% | 18.2% |
| Net margin | 9.8% | 6.6% | 9.4% | 10.0% | 10.1% | 10.1% | 10.5% | 11.5% | 9.9% | 11.7% |
| FCF margin | 10.6% | 6.1% | 6.9% | 10.2% | 12.0% | 5.1% | 12.4% | 11.4% | 9.2% | 11.0% |
| Returns | ||||||||||
| Return on capital | 20.8% | 16.0% | 21.7% | 19.1% | 20.6% | 22.3% | 21.7% | 23.5% | 19.8% | 19.4% |
| Return on capital employed | 23.6% | 25.1% | 24.5% | 19.5% | 21.2% | 23.6% | 24.1% | 26.3% | 22.8% | 22.2% |
| Return on equity | 28.6% | 21.1% | 30.5% | 27.3% | 26.9% | 29.3% | 29.2% | 29.5% | 24.9% | 28.2% |
| Return on assets | 12.4% | 9.1% | 13.0% | 11.7% | 12.4% | 13.3% | 13.4% | 14.6% | 12.5% | 13.0% |
| Growth | ||||||||||
| Revenue growth | 6.8% | 15.3% | 4.1% | β9.3% | 10.5% | 15.9% | 3.8% | 4.5% | 2.9% | 5.3% |
| Net income growth | 22.0% | β22.6% | 48.2% | β3.8% | 11.6% | 16.0% | 7.8% | 15.4% | β11.4% | 23.7% |
| EPS growth | 22.5% | β21.8% | 50.7% | β2.4% | 12.0% | 18.8% | 9.0% | 16.6% | β9.8% | 26.2% |
| FCF growth | 15.3% | β34.3% | 18.0% | 34.6% | 30.6% | β51.2% | 154.6% | β4.5% | β16.5% | 25.4% |
| Share count change | β0.5% | β1.4% | β1.4% | β1.5% | β0.1% | β2.3% | β1.3% | β0.8% | β1.8% | β2.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.8x | 0.8x | 1.0x | 0.9x | 0.6x | 0.9x | 0.8x | 0.5x | 0.8x | 1.5x |
| Debt / equity | 0.7x | 0.6x | 0.7x | 0.6x | 0.5x | 0.6x | 0.5x | 0.4x | 0.5x | 0.8x |
| Interest coverage | 16.6x | 17.7x | 19.5x | 19.6x | 29.6x | 29.8x | 25.0x | 25.4x | 20.5x | 16.7x |
| Current ratio | 2.4x | 2.4x | 2.3x | 2.7x | 2.1x | 2.2x | 1.7x | 1.8x | 1.9x | 2.1x |
| Quick ratio | 1.8x | 1.7x | 1.6x | 1.9x | 1.4x | 1.4x | 1.2x | 1.2x | 1.3x | 1.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.8% | 3.6% | 5.3% | 4.8% | 2.1% | 2.6% | 3.5% | 2.4% | 2.1% | 1.7% |
| Stock comp / revenue | 0.4% | 0.6% | 0.5% | 0.6% | 0.5% | 0.6% | 0.6% | 0.6% | 0.7% | 0.6% |
| Payouts / FCF | 92.4% | 131.0% | 117.3% | 76.4% | 72.7% | 167.8% | 60.1% | 70.2% | 136.3% | 59.2% |
| Quality scores | ||||||||||
| Piotroski F-score | 8.0 | 7.0 | 6.0 | 7.0 | 8.0 | 6.0 | 6.0 | 8.0 | 5.0 | 7.0 |
| Altman Z'' | 5.8 | 6.1 | 5.9 | 6.0 | 6.0 | 6.2 | 5.8 | 6.5 | 6.5 | 5.7 |
| Accruals ratio | β4.5% | β4.2% | β3.8% | β5.9% | β5.0% | 3.2% | β6.9% | β2.8% | β1.8% | β1.2% |
Source: SEC EDGAR XBRL filings (CIK 0000029644). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.